We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.31%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$684M
AUM Growth
+$191M
(+39%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
25.54%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
1,116
New
453
Increased
148
Reduced
137
Closed
375
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$66.9M |
| 2 |
Tesla
TSLA
|
+$17M |
| 3 |
Starbucks
SBUX
|
+$7.73M |
| 4 |
Alibaba
BABA
|
+$5.61M |
| 5 |
Ferguson
FERG
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$8.46M |
| 2 |
United Parcel Service
UPS
|
+$6.5M |
| 3 |
Medtronic
MDT
|
+$5.4M |
| 4 |
Palo Alto Networks
PANW
|
+$5.27M |
| 5 |
3M
MMM
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.5% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 11.88% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Adicet Bio
ACET
$76.7M
| $200K | 0.03% |
+1,400
| New | +$349K |
|
602
Tenet Healthcare
THC
$22.6B
| $200K | 0.03% |
4,100
-8,800
| -68% | -$407K |
|
|
NVTA
603
DELISTED
Invitae Corporation
NVTA
| $199K | 0.03% |
+107,135
| New | +$262K |
|
604
Blue Owl Capital
OBDC
$5.47B
| $198K | 0.03% |
+17,100
| New | +$205K |
|
|
STKL
605
DELISTED
SunOpta
STKL
| $195K | 0.03% |
+23,156
| New | +$219K |
|
606
ADT
ADT
$5.38B
| $193K | 0.03% |
+21,300
| New | +$189K |
|
607
Cerence
CRNC
$368M
| $193K | 0.03% |
+10,418
| New | +$178K |
|
608
Extreme Networks
EXTR
$3.92B
| $190K | 0.03% |
10,372
-28,200
| -73% | -$494K |
|
|
DCT
609
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $189K | 0.03% |
+15,693
| New | +$180K |
|
610
Fate Therapeutics
FATE
$270M
| $189K | 0.03% |
18,736
+3,900
| +26% | +$73.2K |
|
611
Coherus Oncology
CHRS
$222M
| $188K | 0.03% |
+23,800
| New | +$183K |
|
612
Domo
DOMO
$170M
| $186K | 0.03% |
+13,046
| New | +$202K |
|
613
Ecopetrol
EC
$32.5B
| $183K | 0.03% |
+17,475
| New | +$170K |
|
614
TransAlta
TAC
$4.03B
| $180K | 0.03% |
+20,076
| New | +$180K |
|
615
Capitol Federal Financial
CFFN
$1.09B
| $178K | 0.03% |
+20,576
| New | +$170K |
|
616
AST SpaceMobile
ASTS
$16.9B
| $177K | 0.03% |
+36,777
| New | +$222K |
|
617
PROG Holdings
PRG
$1.81B
| $176K | 0.03% |
10,438
-7,200
| -41% | -$123K |
|
618
RLX Technology
RLX
$2.43B
| $176K | 0.03% |
+76,400
| New | +$136K |
|
619
indie Semiconductor
INDI
$678M
| $173K | 0.03% |
+29,716
| New | +$219K |
|
|
FIRY
620
Firy Inc
FIRY
$154M
| $172K | 0.03% |
+16,945
| New | +$311K |
|
|
MNTV
621
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $165K | 0.02% |
+23,600
| New | +$170K |
|
622
ADMA Biologics
ADMA
$2.04B
| $163K | 0.02% |
+42,000
| New | +$130K |
|
623
Paysafe
PSFE
$463M
| $163K | 0.02% |
+11,709
| New | +$189K |
|
624
Televisa
TV
$1.47B
| $161K | 0.02% |
+35,400
| New | +$184K |
|
|
TWOU
625
DELISTED
2U Inc
TWOU
| $156K | 0.02% |
+830
| New | +$165K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Bayesian Capital Management held 1,116 positions worth $684M, up 39% from $493M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bayesian Capital Management deployed $175M of net new capital in Q4 2022, opening 453 new positions and adding to 148 existing holdings. Its largest new stake was Tesla: 89,769 shares worth $11.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $5.4M trimmed.
- Bayesian Capital Management's largest Q4 2022 buy was Tesla: 89,769 shares worth $11.1M.
- Bayesian Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $66.9M increase.
- Bayesian Capital Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $5.4M.
- Bayesian Capital Management fully exited Micron Technology in Q4 2022, selling an estimated $8.46M.
- Bayesian Capital Management's ten largest holdings make up 22% of its $684M portfolio in Q4 2022.
- Bayesian Capital Management opened 453 new positions and closed 375 in Q4 2022.
- Bayesian Capital Management's portfolio value rose 39% quarter-over-quarter to $684M.
Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.